Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic performance of EUS-guided tissue acquisition for solid pancreatic lesions ≤10 mm.
Kawasaki Y, Hijioka S, Nagashio Y, Ohba A, Maruki Y, Takeshita K, Takasaki T, Agarie D, Hagiwara Y, Hara H, Okamoto K, Yamashige D, Kondo S, Morizane C, Ueno H, Mizui T, Takamoto T, Nara S, Ban D, Esaki M, Saito Y, Hiraoka N, Okusaka T. Kawasaki Y, et al. Among authors: hijioka s. Endosc Ultrasound. 2024 Mar-Apr;13(2):115-122. doi: 10.1097/eus.0000000000000052. Epub 2024 Apr 5. Endosc Ultrasound. 2024. PMID: 38947747 Free PMC article.
A novel technique for endoscopic transpapillary "mapping biopsy specimens" of superficial intraductal spread of bile duct carcinoma (with videos).
Hijioka S, Hara K, Mizuno N, Imaoka H, Mekky MA, Nagashio Y, Sekine M, Tajika M, Tanaka T, Ishihara M, Hosoda W, Yatabe Y, Shimizu Y, Niwa Y, Yamao K. Hijioka S, et al. Gastrointest Endosc. 2014 Jun;79(6):1020-5. doi: 10.1016/j.gie.2014.01.040. Epub 2014 Mar 25. Gastrointest Endosc. 2014. PMID: 24674353 No abstract available.
Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
Nagashio Y, Hijioka S, Mizuno N, Hara K, Imaoka H, Bhatia V, Niwa Y, Tajika M, Tanaka T, Ishihara M, Shimizu Y, Hosoda W, Yatabe Y, Yamao K. Nagashio Y, et al. Among authors: hijioka s. Pancreatology. 2014 Nov-Dec;14(6):503-9. doi: 10.1016/j.pan.2014.09.011. Epub 2014 Oct 17. Pancreatology. 2014. PMID: 25458668
Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study.
Hijioka S, Hosoda W, Matsuo K, Ueno M, Furukawa M, Yoshitomi H, Kobayashi N, Ikeda M, Ito T, Nakamori S, Ishii H, Kodama Y, Morizane C, Okusaka T, Yanagimoto H, Notohara K, Taguchi H, Kitano M, Yane K, Maguchi H, Tsuchiya Y, Komoto I, Tanaka H, Tsuji A, Hashigo S, Kawaguchi Y, Mine T, Kanno A, Murohisa G, Miyabe K, Takagi T, Matayoshi N, Yoshida T, Hara K, Imamura M, Furuse J, Yatabe Y, Mizuno N. Hijioka S, et al. Clin Cancer Res. 2017 Aug 15;23(16):4625-4632. doi: 10.1158/1078-0432.CCR-16-3135. Epub 2017 Apr 28. Clin Cancer Res. 2017. PMID: 28455360
Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy.
Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T. Shibuya H, et al. Among authors: hijioka s. Cancer Chemother Pharmacol. 2018 Oct;82(4):661-668. doi: 10.1007/s00280-018-3656-y. Epub 2018 Jul 27. Cancer Chemother Pharmacol. 2018. PMID: 30054710
219 results